Down Syndrome and Obesity Management: Lifestyle Observations Made in the Framework of the GO-DS21 Project and Clinical Recommendations
Nutrients · 11.03.2026 · 18 (6) · 886
DOI: 10.3390/nu18060886 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, online erschienen am 11.03.2026. Verfasst von Maria Gomis-González und 6 weiteren Autor:innen. Beteiligte Einrichtung: Integrative Pharmacology and Systems Neurosciences Research Group, Neurosciences Research Program, Hospital del Mar Research Institute, 08003 Barcelo…. Hauptthemen laut MEDLINE: Down Syndrome, Life Style, Obesity, Obesity Management. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU H2020 Research Program, EU Horizon 2020 program.
Abstract (Originalsprache)
Introduction/background: Individuals with Down syndrome (DS) face a higher and earlier risk of overweight and/or obesity than the general population, influenced by factors like limited physical activity, suboptimal diet, stress, and sleep disorders. Despite the impact these lifestyle factors can have, there is a significant lack of robust, evidence-based guidelines for managing overweight and obesity in these individuals, particularly for the adult population.
Results
Based on findings from an observational study across three European sites, within the EU Horizon-2020 GO-DS21 project, in this short communication, we highlight some key insights for developing effective prevention and management strategies for overweight and obesity in people with Down syndrome.
Conclusions
In general terms, effective overweight and obesity management demands a holistic approach, integrating tailored diet and physical activity and actively addressing co-occurring health conditions. Moreover, the active participation of the family and peers is crucial for promoting sustainable healthy habits and for enhancing the overall quality of life of people with Down syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Integrative Pharmacology and Systems Neurosciences Research Group, Neurosciences Research Program, Hospital del Mar Research Institute, 08003 Barcelona, Spain.
- Centre for Endocrinology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
- Institut Jérôme Lejeune, 75015 Paris, France.
- Centre for Genomic Regulation (CRG), 08003 Barcelona, Spain.
- The Barcelona Institute for Science and Technology (BIST) Centro de Investigación Biomédica en Red de Enfermedades Raras Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003 Barcelona, Spain.
ORCID-Profile: Li F Chan, Anne Hiance-Delahaye, Mara Dierssen
Förderung
- EU H2020 Research Program
- EU Horizon 2020 program
Zitieren
APA
Gomis-González, M., Chan, L. F., Hiance-Delahaye, A., Dierssen, M., Strydom, A., de la Torre, R., & Go-Ds Consortium (2026). Down Syndrome and Obesity Management: Lifestyle Observations Made in the Framework of the GO-DS21 Project and Clinical Recommendations. Nutrients, 18(6), 886. https://doi.org/10.3390/nu18060886
Vancouver
Gomis-González M, Chan LF, Hiance-Delahaye A, Dierssen M, Strydom A, de la Torre R, et al. Down Syndrome and Obesity Management: Lifestyle Observations Made in the Framework of the GO-DS21 Project and Clinical Recommendations. Nutrients. 2026;18(6):886. doi:10.3390/nu18060886
BibTeX
@article{GomisGonzlez2026,
author = {Gomis-González, Maria and Chan, Li F and Hiance-Delahaye, Anne and Dierssen, Mara and Strydom, Andre and de la Torre, Rafael and Go-Ds Consortium},
title = {Down Syndrome and Obesity Management: Lifestyle Observations Made in the Framework of the GO-DS21 Project and Clinical Recommendations},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {6},
pages = {886},
doi = {10.3390/nu18060886}
}
EUVIMED